Literature DB >> 1206095

The effect of somatostatin on TSH levels in patients with primary hypothyroidism.

C Lucke, B Höffken, A von zur Mühlen.   

Abstract

Somatostatin, a growth hormone inhibiting factor (GHIF), was infused into 8 patients with primary hypothyroidism at a dosage of 1000 mug for 105 min. GHIF caused a suppression of TSH levels from 42.6 to 76.9% of preinfusion levels with a mean nadir of 65.0 +/- 4.0%;(mean +/- SEM).

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1206095     DOI： 10.1210/jcem-41-6-1082

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


  9 in total

1.  Constitutive somatostatin receptor activity determines tonic pituitary cell response.

Authors:  Anat Ben-Shlomo; Cuiqi Zhou; Oxana Pichurin; Vera Chesnokova; Ning-Ai Liu; Michael D Culler; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2009-01-08

Review 2.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

3.  Pyridostigmine and metoclopramide do not restore the TSH response to TRH inhibited by L-thyroxine treatment in children with goiter.

Authors:  G Radetti; S Bernasconi; M Bozzola; C Volta; G Tonini; L Gentili; F Rigon
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

4.  [Somatostatin -- a review (author's transl)].

Authors:  C Lucke; H J Mitzkat; A von zur Mühlen
Journal:  Klin Wochenschr       Date:  1976-04-01

5.  The role of somatostatin (octreotide) in the regulation of melatonin secretion in healthy volunteers and in patients with primary hypothyroidism.

Authors:  J Wikner; L Wetterberg; S Röjdmark
Journal:  J Endocrinol Invest       Date:  1999 Jul-Aug       Impact factor: 4.256

Review 6.  Risk factors of subclinical hypothyroidism and the potential contribution to miscarriage: A review.

Authors:  Shuhei So; Fumiko Tawara
Journal:  Reprod Med Biol       Date:  2020-03-18

7.  Abnormal daily periodicity of serum thyrotropin (TSH) and evidence for defective TSH suppression in a case of non-neoplastic syndrome of inappropriate TSH secretion.

Authors:  S Benvenga; G A Sobbrio; F Vermiglio; L Li Calzi; S Cannavò; F Consolo; F Trimarchi
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

8.  Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin.

Authors:  M Bermann; C A Jaffe; W Tsai; R DeMott-Friberg; A L Barkan
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  Comparative distribution of somatostatin and somatostatin receptors in PTU-induced hypothyroidism.

Authors:  Sneha Singh; Rishi K Somvanshi; Vandana Panda; Ujendra Kumar
Journal:  Endocrine       Date:  2020-04-25       Impact factor: 3.633
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.